THR shareholders have been suffering because of the optimism shown by the Opes Prime brokerage clients having bought around 4 million shares and a similar number of options; these are now being liquidated by Goldmans on behalf of the ANZ bank which had financed Opes.
I am not sure of how many shares remain in the selling parcel, but according to my best guess it should be less than one million; these could be completed this week. The options still have a lot to sell, but if the share selling ceases and the share price rises, the option price will rise and become more attractive to investors.
Then we should be able to concentrate on arranging finance for Molyhil --$70 million-- and drilling for uranium at Harts Range. A suitable rig MUST SURELY be available by now.
On a more positive note, this long period of shareholder suffering has developed a large charting base which will give us a reading to 50 cents when the Opes shares are gone. Conix
- Forums
- ASX - By Stock
- THR
- key issues for thr investors this week
THR
thor energy plc
Add to My Watchlist
0.00%
!
0.9¢

key issues for thr investors this week
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.397M |
Open | High | Low | Value | Volume |
0.9¢ | 1.1¢ | 0.9¢ | $4.757K | 497.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1387728 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1317728 | 0.009 |
7 | 1584333 | 0.008 |
6 | 1643979 | 0.007 |
4 | 1006832 | 0.006 |
2 | 577727 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 993871 | 4 |
0.015 | 243352 | 1 |
0.016 | 100000 | 1 |
0.017 | 165000 | 3 |
0.018 | 102200 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
THR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online